Chemical Compound

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic acid; 5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-, [1R-[1a(Z),2ss(R*),3a,5a]]-; (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl]hept-5-enoic acid; 13,14-Dihydro-17-phenyl-18,19,20-trinor-PGF2a; Latanoprost acid; PhXA 85; Latanoprost Related Compound E (USP)

CAS Registry Number 41639-83-2
返回搜索 申请报价
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic acid; 5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-, [1R-[1a(Z),2ss(R*),3a,5a]]-; (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl]hept-5-enoic acid; 13,14-Dihydro-17-phenyl-18,19,20-trinor-PGF2a; Latanoprost acid; PhXA 85; Latanoprost Related Compound E (USP) 结构式
Primary record

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic acid; 5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-, [1R-[1a(Z),2ss(R*),3a,5a]]-; (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl]hept-5-enoic acid; 13,14-Dihydro-17-phenyl-18,19,20-trinor-PGF2a; Latanoprost acid; PhXA 85; Latanoprost Related Compound E (USP)

库存
1,379 克
纯度
98.2 %
CAS
41639-83-2

化合物标识与属性

CAS
41639-83-2
PubChem CID
6441636
SMILES
C1[C@H]([C@@H]([C@H]([C@H]1O)C/C=C\CCCC(=O)O)CC[C@H](CCC2=CC=CC=C2)O)O
Canonical SMILES
O=C(O)CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O

名称与同义词

  • Latanoprost acid
  • Latanoprostacid
  • Phxa 85
  • Latanprost acid
  • 41639-83-2
  • latanoprost free acid
  • Phxa-85
  • latanoprost-free acid
  • Latanprost Free Acid
  • PHXA85
  • Latanoprost (free acid)
  • AC1O5VOE
  • RefChem:798532
  • Latanoprost impurity H CRS
  • Latanoprost Related Compound E
  • CHEMBL1050
  • latanoprost (free acid form)
  • CHEBI:63925
  • HNPFPERDNWXAGS-NFVOFSAMSA-N
  • GTPL1960
  • orb1707093
  • SCHEMBL1313159
  • UNII-EJ85341990
  • C23H34O5
  • DTXSID6040531
  • MFCD08056084
  • GLXC-05410
  • HMS3648J04
  • Latanoprost acid, >=98% (HPLC)
  • BDBM50485606
  • ZINC13589951
  • AKOS037645066
  • CID6441636
  • FL24853
  • HY-113756A
  • LATANOPROST IMPURITY H [EP IMPURITY]
  • EJ85341990
  • NCGC00165820-01
  • AS-56760
  • DA-74907
  • SC-44791
  • LATANOPROST RELATED COMPOUND E [USP-RS]
  • J808.609E
  • CS-0068357
  • LATANOPROST IMPURITY H (EP IMPURITY)
  • Z6154
  • LATANOPROST RELATED COMPOUND E (USP-RS)
  • LATANOPROST RELATED COMPOUND E [USP IMPURITY]
  • 13,14-DIHYDRO-17-PHENYL TRINOR PGF2.ALPHA.
  • Latanoprost Acid; Latanoprost Related Compound E
  • 13,14-dihydro-17-phenyl-18,19,20-trinor-PGF2alpha
  • 639L832
  • A825618
  • SR-01000946512
  • 13,14-DIHYDRO-17-PHENYL TRINOR PGF2ALPHA
  • SR-01000946512-1
  • LATANOPROST RELATED COMPOUND E (USP IMPURITY)
  • Q27078867
  • (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoic acid
  • (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoic acid
  • (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid
  • 13,14-Dihydro-17-phenyl-18,19,20-trinor-PGF2|A
  • B1289-092108
  • (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid
  • 13,14-DIHYDRO-17-PHENYL-18,19,20-TRINOR-PGF2.ALPHA.
  • (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic Acid
  • (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic acid
  • 5-HEPTENOIC ACID, 7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((3R)-3-HYDROXY-5-PHENYLPENTYL)CYCLOPENTYL)-, (5Z)-
  • Z-7-[(1R,2R,3R,5S)-3,5-bis(oxidanyl)-2-[(3R)-3-oxidanyl-5-phenyl-pentyl]cyclopentyl]hept-5-enoic acid
  • (5Z,15R)-9alpha,11alpha,15-Trihydroxy-18,19,20-trinor-17-phenylprost-5-en-1-oic acid
  • 7-[3,5-DIHYDROXY-2-(3-HYDROXY-5-PHENYLPENTYL)CYCLOPENTYL]HEPT-5-ENOIC ACID
  • Latanoprost Related Compound E, United States Pharmacopeia (USP) Reference Standard
  • (5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoic acid
  • (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic acid; 5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-, [1R-[1a(Z),2ss(R*),3a,5a]]-; (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl]hept-5-enoic acid; 13,14-Dihydro-17-phenyl-18,19,20-trinor-PGF2a; Latanoprost acid; PhXA 85; Latanoprost Related Compound E (USP)
  • (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)-cyclopentyl)hept-5-enoic acid
  • (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenyl-pentyl]cyclopentyl]hept-5-enoic acid
  • 5-Heptenoic acid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-,(5Z)-
  • 682-021-0
  • 7WT